Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma

Fig. 3

Relationship between Gene Expression and Clinical Characteristics, Kaplan-Meier Survival Analysis and ROC analysis. A, E, Pathologic stage of ZEB1 and ZEB2. B, F, respectively showing the tumor stage of ZEB1 and ZEB2 expressions in KIRC. C, G, metastasis stage of ZEB1 and ZEB2. D, H Histologic grade of ZEB1 and ZEB2 expressions. I, Survival curves of overall survival (OS), disease-specific survival (DSS), and progress-free interval (PFI) between ZEB1-high and -low patients with KIRC. K, OS, DSS, and PFI between ZEB2-high and -low patients with KIRC. J, L, Receiver operating characteristic curve of ZEBs in diagnosis of KIRC. Note: ns (not significant); **P < 0.01; ***P < 0.001

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us